Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.
Institute of Biostatistics, School of Life Sciences, Human Phenome Institute, Fudan University, Shanghai, China.
Thorac Cancer. 2023 Nov;14(33):3295-3308. doi: 10.1111/1759-7714.15121. Epub 2023 Oct 5.
Lung adenocarcinoma (LUAD) is a fatal form of lung cancer with a poor prognosis. Coagulation system had been confirmed closely related to tumor progression and the hypercoagulable state encouraged the immune infiltration and development of tumor cells, leading to a poor prognosis in cancer patients. However, the use of the coagulation-related genes (CRGs) for prognosis in LUAD has yet to be determined. In this study, we constructed an immune-related signature (CRRS) and identified a potential coagulation-related biomarker (P2RX1).
We obtained a total of 209 CRGs based on two coagulation-related KEGG pathways, then developed the CRRS signature by using the TCGA-LUAD RNA-seq data via the procedure of LASSO-Cox regression, stepwise-Cox regression, univariate and multivariate Cox regression. Grouped by the CRRS, Kaplan-Meier survival curves and receiver operating characteristic curves were drawn for the training and validation sets, respectively. In addition, single-sample gene set enrichment analysis was exploited to explore immune infiltration level. Moreover, immunophenotypes and immunotherapy grouped by CRRS were further analyzed.
We developed an immune-related signature (CRRS) composed of COL1A2, F2, PLAUR, C4BPA, and P2RX1 in LUAD. CRRS was an independent risk factor for overall survival and displayed stable and powerful performance. Additionally, CRRS possessed distinctly superior accuracy than traditional clinical variables and molecular features. Functional analysis indicated that the differentially high expressed genes in the low-risk group significantly enriched in T cell and B cell receptor signaling pathways. The low-risk group was sensitive to anti-PD-1/PD-L1 immunotherapy and displayed abundant immune infiltration and immune checkpoint gene expression. Finally, we identified an independent prognostic gene P2RX1. Low expression of P2RX1 associated with poor overall survival and decreased immune infiltration.
Our study revealed a significant correlation between CRRS and immune infiltration. CRRS could serve as a promising tool to improve the clinical outcomes for individual LUAD patients.
肺腺癌 (LUAD) 是一种致命的肺癌形式,预后不良。凝血系统已被证实与肿瘤进展密切相关,高凝状态促进了肿瘤细胞的免疫浸润和发展,导致癌症患者预后不良。然而,凝血相关基因 (CRGs) 在 LUAD 中的预后应用尚未确定。在这项研究中,我们构建了一个免疫相关特征 (CRRS),并确定了一个潜在的凝血相关生物标志物 (P2RX1)。
我们基于两个凝血相关 KEGG 途径获得了总共 209 个 CRGs,然后使用 TCGA-LUAD RNA-seq 数据通过 LASSO-Cox 回归、逐步 Cox 回归、单变量和多变量 Cox 回归的程序开发了 CRRS 特征。根据 CRRS 对训练集和验证集进行分组,分别绘制 Kaplan-Meier 生存曲线和接收者操作特征曲线。此外,还利用单样本基因集富集分析来探索免疫浸润水平。此外,还进一步分析了根据 CRRS 分组的免疫表型和免疫治疗。
我们在 LUAD 中开发了一个由 COL1A2、F2、PLAUR、C4BPA 和 P2RX1 组成的免疫相关特征 (CRRS)。CRRS 是总生存期的独立危险因素,具有稳定且强大的性能。此外,CRRS 比传统的临床变量和分子特征具有明显更高的准确性。功能分析表明,低风险组中差异高表达的基因显著富集在 T 细胞和 B 细胞受体信号通路中。低风险组对抗 PD-1/PD-L1 免疫治疗敏感,表现出丰富的免疫浸润和免疫检查点基因表达。最后,我们确定了一个独立的预后基因 P2RX1。P2RX1 低表达与总生存期不良和免疫浸润减少相关。
我们的研究揭示了 CRRS 与免疫浸润之间的显著相关性。CRRS 可以作为一种有前途的工具,改善个体 LUAD 患者的临床结局。